Article

Engineering the Graft–Immune Interface: CAR-T Cell Strategies for Precision Organ Transplantation

2026-07-07

Abstract excerpt

<title>Abstract</title> <p>Organ transplantation remains limited by a central paradox: the recipient immune system must be restrained strongly enough to preserve the graft, yet not so globally that the patient is left vulnerable to infection, malignancy, metabolic toxicity, and drug-related organ injury. This critical narrative perspective reframes rejection as an antigen-directed interaction at the graft–immune...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: be7d684f-e285-5c47-a96e-8ccbf63e5de8
DOI: 10.21203/rs.3.rs-10250137/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Engineering the Graft–Immune Interface: CAR-T Cell Strategies for Precision Organ TransplantationDOI 10.21203/rs.3.rs-10250137/v1Read

Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipients.Semantic proximity Read

Allogeneic CAR-T Cells: Engineering Around Host ImmunitySemantic proximity Read

Matching or genetic engineering of HLA Class I and II facilitates successful allogeneic ‘off-the-shelf’ regulatory T cell therapySemantic proximity Read

Chimeric anti-HLA antibody receptor engineered human regulatory T cells suppress alloantigen-specific B cells from pre-sensitized transplant recipientsSemantic proximity Read

HLA-G engineering reprograms CAR-T cells with an immune privilegeSemantic proximity Read

Off-the-Shelf Chimeric Antigen Receptor T CellsSemantic proximity Read

Unlocking the potential of Tregs: innovations in CAR technologySemantic proximity Read

Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejectionSemantic proximity Read

Depletion of alloreactive B cells by chimeric alloantigen receptor T cells with drug resistance to prevent antibody-mediated rejection in solid organ transplantationSemantic proximity Read

Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune toleranceSemantic proximity Read

Automated GMP-Compatible Production of Universal CAR Tregs for Organ-Targeted Tolerance InductionSemantic proximity Read

CAR T-cell therapy - Paving the way for sensitized kidney transplant patientsSemantic proximity Read